Lifecore Biomedical Inc. (LFCR) — Long-term Investment Intensity

Latest as of May 2021: 9.0%

Lifecore Biomedical Inc. (LFCR) has a Long-term Investment Intensity of 9.0% as of May 2021. Long-term investments of $45.10 Million represent 9.0% of total assets of $502.92 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check LFCR asset resilience ratio to evaluate the company's liquid asset resilience ratio.

LT Investment Intensity

9.0%
LT Investments / Total Assets

Long-term Investments

$45.10 Million
USD

Total Assets

$502.92 Million
USD

Country

USA
NASDAQ

Lifecore Biomedical Inc. Long-term Investment Intensity (2019–2021)

This chart shows how Lifecore Biomedical Inc.'s Long-term Investment Intensity has evolved across 3 annual periods from 2019 to 2021. As of May 2021, the intensity stands at 9.0%, reflecting long-term investments of $45.10 Million against total assets of $502.92 Million USD. For the complete balance sheet picture, see how large is Lifecore Biomedical Inc.'s balance sheet.

Annual Long-term Investment Intensity for Lifecore Biomedical Inc. (2019–2021)

The table below presents the year-by-year Long-term Investment Intensity for Lifecore Biomedical Inc. from 2019 to 2021, covering 3 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read debt load of Lifecore Biomedical Inc. for a breakdown of total debt and financial obligations.

Year LT Investment Intensity LT Investments (USD) Total Assets Change (pp)
2021 9.0% $45.10 Million $502.92 Million ▼ -1.5 pp
2020 10.5% $56.90 Million $541.31 Million ▼ -1.3 pp
2019 11.8% $61.10 Million $519.09 Million
pp = percentage points